https://doi.org/10.1016/j.ahj.2014.07.028
L
Lisa G. Berdan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
5.5K
Citations
35
h-index
49
i10-index
Lisa G. Berdan is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Acute Myocardial Infarction Research & Coronary Interventions and Diagnostics & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 35, co-authored 57 publications.
Papers by this author
worksEffect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
2014 · American Heart Journal · 409 citations
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Journal of the American College of Cardiology · 131 citations
https://doi.org/10.1016/j.jacc.2021.04.102
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort
2024 · Annals of Internal Medicine · 41 citations
https://doi.org/10.7326/m24-0737
The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study
2021 · Trials · 23 citations
https://doi.org/10.1186/s13063-021-05397-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat